Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    general medicine

    Eosinophilic granulomatosis with polyangiitis

    Also known as: EGPA, Churg–Strauss syndrome, Allergic granulomatosis with polyangiitis, Allergic granulomatous angiitis

    Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic small-to-medium vessel vasculitis, frequently characterised by asthma and peripheral eosinophilia. Clinical manifestations include involvement of the peripheral nervous system, integumentary system, gastrointestinal tract, and myocardium. Negative ANCA status or lower absolute eosinophil counts do not preclude significant organ pathology; therefore, specialist management involving glucocorticoids, immunosuppressants, and biologics is essential. The cited evidence, comprising an asthma bibliometric analysis, a retrospective cohort study, and two case reports, does not evaluate the efficacy of acupuncture or Chinese herbal medicine. In clinical practice, TCM is limited to adjunctive supportive care for symptomatic management in medically stable patients. These traditional patterns provide a framework for symptomatic assessment but are not validated diagnostic markers or indices of disease activity in EGPA.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain a comprehensive symptom log, documenting dyspnoea, sleep disturbances, fatigue, integumentary changes, and new-onset sensory or motor deficits for specialist review.
    • •Adhere strictly to the prescribed pharmacological regimen and monitoring schedule; do not titrate corticosteroids or alter biologic dosages without specialist authorisation.
    • •Balance low-impact physical activity with sufficient rest periods, and request a rehabilitative referral if peripheral neuropathy impairs gait or postural stability.
    • •Cessation of smoking and vaping is indicated; patients should consult their medical team regarding immunisation status and infection-prevention protocols.

    Cautions & Contraindications

    See sources
    • •Defer acupuncture and herbal initiation during suspected active organ-threatening disease or unexplained deterioration; prioritise specialist or emergency assessment. This is a clinical precaution informed by the organ involvement described in the cohort, not a tested TCM safety finding.[]
    • •Do not use TCM as a reason to stop, reduce or delay prescribed glucocorticoids, immunosuppressants or biologics. The supplied treatment reports concern conventional medicines, not evidence that adjunctive herbs or acupuncture can replace them.[,]
    • •With neuropathy, inspect skin and protective sensation before treatment; avoid needling ulcerated, infected or poorly sensate areas and avoid heat over insensate skin. The cited reports establish neurological involvement, not procedural safety; these are precautionary practice requirements.[,]

    When to reassess or seek care again

    See sources

    Review supportive care after 2–4 weeks using baseline and repeat 0–10 fatigue, cough-discomfort and sleep scores, functional activity and adverse effects. Review symptoms before every session. Stop or revise adjunctive treatment if there is no meaningful improvement by four weeks. New respiratory, cardiac, neurological, skin or gastrointestinal findings require prompt medical reassessment rather than a formula change. Disease activity, blood tests and organ monitoring remain the specialist team's responsibility; symptom improvement alone does not establish remission.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Medicine · 2026
    2. Respiratory research · 2026
    3. Medicine · 2026
    4. Frontiers in pharmacology · 2025

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.